No need to worry about monkeypox, says Pfizer CEO – just days after Biden said ‘everyone’ should be concerned

No need to worry about monkeypox, says Pfizer CEO – just days after Biden said ‘everyone’ should be concerned

Pfizer's CEO said he "wouldn't worry much" about the spread of monkeypox during an interview with at the World Economic Forum in Davos, Switzerland. Albert Bourla's comments come just days after that detecting the disease in the US is "something that everybody should be concerned about." There has been increasing concern about the spread of monkeypox in Europe in recent weeks. The rare disease is usually spread by wild animals in central or West Africa but has suddenly started appearing in more countries. The UK has reported of monkeypox as of Wednesday. The was identified in Massachusetts on May 18, prompting the Centers for Disease Control and Prevention to monitor a further people for the disease. Bourla said: "I don't have all the information ahead of me. With everything I know, I wouldn't worry much." Although the virus "clearly doesn't transmit as much as other viruses including COVID," he said: "That doesn't mean that we should relax. I think we should monitor where the situation goes." Bourla also told that monkeypox was "not that transmissible", meaning it was "very difficult to become a pandemic. There are already medicines and vaccines that can work." testing potential vaccines for monkeypox in pre-clinical